Literature DB >> 22949144

Somatic mosaicism of PCDH19 mutation in a family with low-penetrance EFMR.

A Terracciano1, N Specchio, F Darra, A Sferra, B Dalla Bernardina, F Vigevano, E Bertini.   

Abstract

The occurrence of epilepsy with mental retardation limited to females (EFMR; MIM 300088) has been recently associated to mutations in the PCDH19 gene, located on chromosome X and encoding for protocadherin 19. EFMR shows a rare X-linked inheritance wherein affected females may be segregating a mutation through unaffected transmitting males (Fabisiak and Erickson Clin Genet 38(5):353-358, 1990; Juberg and Hellman J Pediatr 79:726-732, 1971; Ryan et al. Nat Genet 17(1):92-95, 1997). The description of a pedigree segregating PCDH19 mutations from unaffected mothers to patients (Depienne et al. Hum Mutat 32:E1959-1975, 2011; Dibbens et al. Neurology 76:1514-1519, 2011) complicates disease inheritance and genetic counseling. In the present study, we describe a PCDH19 mutation segregating from an asymptomatic mother to an EFMR patient. In order to correlate the healthy phenotype with the genotype of the transmitting mother, we quantified in a few tissues the level of the mutant allele by real-time PCR, disclosing a somatic mosaicism. This finding has a great impact on genetic counseling.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22949144     DOI: 10.1007/s10048-012-0342-9

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  14 in total

1.  Recurrence risk of epilepsy and mental retardation in females due to parental mosaicism of PCDH19 mutations.

Authors:  L M Dibbens; R Kneen; M A Bayly; S E Heron; T Arsov; J A Damiano; T Desai; J Gibbs; F McKenzie; J C Mulley; A Ronan; I E Scheffer
Journal:  Neurology       Date:  2011-04-26       Impact factor: 9.910

2.  A familial form of convulsive disorder with or without mental retardation limited to females: extension of a pedigree limits possible genetic mechanisms.

Authors:  K Fabisiak; R P Erickson
Journal:  Clin Genet       Date:  1990-11       Impact factor: 4.438

3.  Spectrum of phenotypes in female patients with epilepsy due to protocadherin 19 mutations.

Authors:  Nicola Specchio; Carla Marini; Alessandra Terracciano; Davide Mei; Marina Trivisano; Federico Sicca; Lucia Fusco; Raffaella Cusmai; Francesca Darra; Bernardo Dalla Bernardina; Enrico Bertini; Renzo Guerrini; Federico Vigevano
Journal:  Epilepsia       Date:  2011-04-11       Impact factor: 5.864

4.  A new familial form of convulsive disorder and mental retardation limited to females.

Authors:  R C Juberg; C D Hellman
Journal:  J Pediatr       Date:  1971-11       Impact factor: 4.406

5.  Metabolic interference and the + - heterozygote. a hypothetical form of simple inheritance which is neither dominant nor recessive.

Authors:  W G Johnson
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

6.  Epilepsy and mental retardation limited to females: an X-linked dominant disorder with male sparing.

Authors:  S G Ryan; P F Chance; C H Zou; N B Spinner; J A Golden; S Smietana
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Protocadherin 19 mutations in girls with infantile-onset epilepsy.

Authors:  C Marini; D Mei; L Parmeggiani; V Norci; E Calado; A Ferrari; A Moreira; T Pisano; N Specchio; F Vigevano; D Battaglia; R Guerrini
Journal:  Neurology       Date:  2010-08-17       Impact factor: 9.910

8.  Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females.

Authors:  Christel Depienne; Delphine Bouteiller; Boris Keren; Emmanuel Cheuret; Karine Poirier; Oriane Trouillard; Baya Benyahia; Chloé Quelin; Wassila Carpentier; Sophie Julia; Alexandra Afenjar; Agnès Gautier; François Rivier; Sophie Meyer; Patrick Berquin; Marie Hélias; Isabelle Py; Serge Rivera; Nadia Bahi-Buisson; Isabelle Gourfinkel-An; Cécile Cazeneuve; Merle Ruberg; Alexis Brice; Rima Nabbout; Eric Leguern
Journal:  PLoS Genet       Date:  2009-02-13       Impact factor: 5.917

9.  Mutations of the ephrin-B1 gene cause craniofrontonasal syndrome.

Authors:  Ilse Wieland; Sibylle Jakubiczka; Petra Muschke; Monika Cohen; Hannelore Thiele; Klaus L Gerlach; Ralf H Adams; Peter Wieacker
Journal:  Am J Hum Genet       Date:  2004-04-29       Impact factor: 11.025

10.  Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in females.

Authors:  Christel Depienne; Oriane Trouillard; Delphine Bouteiller; Isabelle Gourfinkel-An; Karine Poirier; François Rivier; Patrick Berquin; Rima Nabbout; Denys Chaigne; Dominique Steschenko; Agnès Gautier; Dorota Hoffman-Zacharska; Annie Lannuzel; Marilyn Lackmy-Port-Lis; Hélène Maurey; Anne Dusser; Marie Bru; Brigitte Gilbert-Dussardier; Agathe Roubertie; Anna Kaminska; Sandra Whalen; Cyril Mignot; Stéphanie Baulac; Gaetan Lesca; Alexis Arzimanoglou; Eric LeGuern
Journal:  Hum Mutat       Date:  2011-01       Impact factor: 4.878

View more
  9 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

2.  Clinical and genetic aspects of PCDH19-related epilepsy syndromes and the possible role of PCDH19 mutations in males with autism spectrum disorders.

Authors:  J J T van Harssel; S Weckhuysen; M J A van Kempen; K Hardies; N E Verbeek; C G F de Kovel; W B Gunning; E van Daalen; M V de Jonge; A C Jansen; R J Vermeulen; W F M Arts; H Verhelst; A Fogarasi; J F de Rijk-van Andel; A Kelemen; D Lindhout; P De Jonghe; B P C Koeleman; A Suls; E H Brilstra
Journal:  Neurogenetics       Date:  2013-01-20       Impact factor: 2.660

3.  Assessment of copy number variations in the brain genome of schizophrenia patients.

Authors:  Miwako Sakai; Yuichiro Watanabe; Toshiyuki Someya; Kazuaki Araki; Masako Shibuya; Kazuhiro Niizato; Kenichi Oshima; Yasuto Kunii; Hirooki Yabe; Junya Matsumoto; Akira Wada; Mizuki Hino; Takeshi Hashimoto; Akitoyo Hishimoto; Noboru Kitamura; Shuji Iritani; Osamu Shirakawa; Kiyoshi Maeda; Akinori Miyashita; Shin-Ichi Niwa; Hitoshi Takahashi; Akiyoshi Kakita; Ryozo Kuwano; Hiroyuki Nawa
Journal:  Mol Cytogenet       Date:  2015-07-01       Impact factor: 2.009

4.  Genomic mosaicism in paternal sperm and multiple parental tissues in a Dravet syndrome cohort.

Authors:  Xiaoxu Yang; Aijie Liu; Xiaojing Xu; Xiaoling Yang; Qi Zeng; Adam Yongxin Ye; Zhe Yu; Sheng Wang; August Yue Huang; Xiru Wu; Qixi Wu; Liping Wei; Yuehua Zhang
Journal:  Sci Rep       Date:  2017-11-15       Impact factor: 4.379

5.  High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders.

Authors:  Mary Beth Stosser; Amanda S Lindy; Elizabeth Butler; Kyle Retterer; Caitlin M Piccirillo-Stosser; Gabriele Richard; Dianalee A McKnight
Journal:  Genet Med       Date:  2017-08-24       Impact factor: 8.822

6.  PCDH7 interacts with GluN1 and regulates dendritic spine morphology and synaptic function.

Authors:  Yuanyuan Wang; Meghan Kerrisk Campbell; Irene Tom; Oded Foreman; Jesse E Hanson; Morgan Sheng
Journal:  Sci Rep       Date:  2020-07-02       Impact factor: 4.379

7.  X Chromosome Inactivation Pattern and Pregnancy Outcome of Female Carriers of Pathogenic Heterozygous X-Linked Deletions.

Authors:  Yuanyin Zhao; Jia Li; Limeng Dai; Yongyi Ma; Yun Bai; Hong Guo
Journal:  Front Genet       Date:  2021-12-17       Impact factor: 4.599

8.  A rat model of a focal mosaic expression of PCDH19 replicates human brain developmental abnormalities and behaviours.

Authors:  Andrzej W Cwetsch; Ilias Ziogas; Roberto Narducci; Annalisa Savardi; Maria Bolla; Bruno Pinto; Laura E Perlini; Silvia Bassani; Maria Passafaro; Laura Cancedda
Journal:  Brain Commun       Date:  2022-04-05

9.  Mosaicism and incomplete penetrance of PCDH19 mutations.

Authors:  Aijie Liu; Xiaoxu Yang; Xiaoling Yang; Qixi Wu; Jing Zhang; Dan Sun; Zhixian Yang; Yuwu Jiang; Xiru Wu; Liping Wei; Yuehua Zhang
Journal:  J Med Genet       Date:  2018-10-04       Impact factor: 6.318

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.